Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bar (Tel-Aviv, Israel). Targeting targeted therapies: more choices and the best sequences. International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Advances in targeted therapy: the clinicians point of view Source: International Congress 2014 – Update on lung cancer biology for clinicians Year: 2014 What are the targets? Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 TB following targeted and biological therapy: can we predict it? Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Failure of EGFR TKI treatment: mechanisms and current strategies? Source: ERS Research Seminar Year: 2015 When and how to identify resistance mechanisms to targeted therapies Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Gene expression profiling: identifying novel gene targets for therapeutic intervention Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 How to stop LC-fILD progression: an overview of modern therapeutic strategies Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021 Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Diagnostic-therapeutic sequences in advanced NSCLC: how to best standardise and personalise your strategies Source: International Congress 2017 – The latest in lung cancer Year: 2017 Optimizing the target therapy development Source: ERS Research Seminar Year: 2015 Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials? Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019 Bringing it all together: common pathways, emerging therapeutics and future directions Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease Year: 2014 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007